IONS - Ionis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IONS is currently covered by 23 analysts with an average price target of $97.95. This is a potential upside of $55.02 (128.16%) from yesterday's end of day stock price of $42.93.

Ionis Pharmaceuticals's activity chart (see below) currently has 502 price targets and 421 ratings on display. The stock rating distribution of IONS is 86.08% BUY and 13.92% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.08% with an average time for these price targets to be met of 473.05 days.

Highest price target for IONS is $130, Lowest price target is $56, average price target is $97.95.

Most recent stock forecast was given by DAVID LEBOWITZ from BMO. First documented stock forecast 31-Mar-2014.

Best performing analysts who are covering IONS - Ionis Pharmaceuticals:

Yanan Zhu Jim Birchenough Akash Tewari Debjit Chattopadhyay Alethia Young Luca Issi

Currently out of the existing stock ratings of IONS, 68 are a BUY (86.08%), 11 are a HOLD (13.92%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Sep-2026

$66

$23.07 (53.74%)

$54

Buy Since 15-Oct-2026

$88

$45.07 (104.98%)

$46

10 days ago
(15-Oct-2026)

9/10 (90%)

$43.88 (99.46%)

773

Buy Since 07-Apr-2025

$100

$57.07 (132.94%)

$100

1 months 1 days ago
(24-Sep-2026)

6/23 (26.09%)

$56.19 (128.26%)

93

Buy Since 03-Aug-2026

$70

$27.07 (63.06%)

$76

1 months 3 days ago
(22-Sep-2026)

8/10 (80%)

$24.25 (53.01%)

195

Buy Since 01-Mar-2022

$80

$37.07 (86.35%)

$92

1 months 10 days ago
(15-Sep-2026)

6/8 (75%)

$32.75 (69.31%)

372

Show more analysts

Please expand the browser size to see the chart

What is IONS (Ionis Pharmaceuticals) average time for price targets to be met?

On average it took 473 days for the stock forecasts to be reached, with an average price target met ratio of 75.08%.

Which analyst most recently updated their price target on IONS (Ionis Pharmaceuticals)?

David Lebowitz

Which analyst has the most public recommendations on IONS (Ionis Pharmaceuticals)?

David Lebowitz works at BMO and has 16 price targets and 12 ratings on IONS

Which analyst is the currently most bullish on IONS (Ionis Pharmaceuticals)?

Mani Foroohar with the highest potential upside of $86.07

Which analyst is the currently most reserved on IONS (Ionis Pharmaceuticals)?

Esther Rajavelu with the lowest potential downside of -$35.18
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?